About
Issues
Initiatives
Events
Media
Internships
About
Issues
Initiatives
Events
Media
Internships
Category
Product Type
FDA Approves Weekly Injectable Buprenorphine
News
May 24, 2023
FDA Approves Rx Nasal Spray to Reverse Opioid Poisoning
News
May 23, 2023
Health Policy Advocates Oppose Federal Opioid Treatment Bill
CUSP Research
May 17, 2023
Good Intentions Alone Won’t Reduce Drug Poisonings
News
May 16, 2023
Health Policy Advocates Petition FDA to Recall Software
News
May 12, 2023
CUSP Files FDA Citizen Petition to Protect Patients
CUSP Research
April 28, 2023
Barnes to Speak at 2023 Rx Summit
News
April 6, 2023
DEA Proposes Rules for Permanent Telemedicine Flexibilities
News
March 1, 2023
Center for U.S. Policy Welcomes Distinguished Leaders to Its Board of Directors
February 8, 2023
Cost of Opioid Use Disorder
News
February 5, 2023
DEA To Propose Telehealth Regulations
News
February 2, 2023
FDA Announces Need for New Regulatory Pathway for CBD
News
January 30, 2023
More
« Previous